Skip to main content
. 2016 Feb 27;51(1):97–106. doi: 10.3233/JAD-150953

Fig.3.

Fig.3

Difference in clinical diagnostic performance of CSF biomarkers for discriminating progressive from stable MCI when a shift in concentration was induced to the true (=observed) biomarker analyte values, followed by using the IWG-2 criteria in which the three biomarkers are included.